Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mercury Laboratories Ltd has informed BSE that its Board meeting is scheduled for May 29, 2026 to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026. The meeting will also consider dividend recommendations for FY 2026, subject to shareholder approval at the ensuing AGM. The company has confirmed that the Trading Window has been closed since April 1, 2026 and will remain closed until 48 hours after the financial results are declared. This is a standard regulatory intimation filed under SEBI LODR regulations. No specific financial figures or performance details are provided in this announcement.
This is a routine prior intimation filing and does not itself contain material financial information. The actual impact on the stock will depend on the financial results to be disclosed after the May 29, 2026 board meeting. The closed trading window prevents insider trading ahead of the results announcement.